Following the buy-back of 83,333,333 shares of common stock via a dutch auction tender offer by Amgen Inc. (USA, Constituent), resulting in a market capitalisation change greater than USD 2bn, FTSE announces the following changes: | INDEX | CHANGE | EFFECTIVE FROM
START OF TRADING | | FTSE All-World Index | Amgen (USA, 2023607) will remain in the index with a decreased shares in issue total of 793,210,942 and an unchanged investability weight of 100%.
| 28 December 2011 | | FTSE World Index Ex-Multinationals | Amgen will remain in the index as detailed above. | 28 December 2011 | | FTSE Global Style Index | Amgen will remain in the index as detailed above. | 28 December 2011 |
For further information or general enquiries please contact us at info@ftse.com or call: | Client Services in UK: | Tel: +44 (0) 20 7866 1810 | | Client Services in Europe, Middle East & Africa: | Tel: +44 (0) 20 7866 1810 | | Client Services in US: | New York: (Domestic) + 1 888 747 FTSE (3873) / (International): +1 212 314 1139 | | Client Services in Asia Pacific: | Hong Kong: + 852 2164 3333 Australia:(Domestic Toll-Free) + 1800 653 680 / (International) + 61 (2) 9293 2864 Japan + 81 (3) 3581 2764 |
Alternatively please visit our website at www.ftse.com |
